Depression and other mood disorders are highly prevalent conditions that can have a significant impact on individuals, leading to disability and potentially reducing life expectancy by many years.
Single-molecule detection has opened an entirely new direction in life science research. The interaction between biomolecular components within a cell is complex and dynamic, with bulk analytical methods only able to provide averaging information, typically from multi-cellular samples.
From sunscreens to vaccines, most of the modern technology we rely on today is dependent on our ability to precisely manufacture complex molecules with precise chemical properties.
The discovery of drugs that target ion channels presents a substantial opportunity for treating a wide range of medical conditions, including chronic pain, stroke, epilepsy, multiple sclerosis, and rheumatoid arthritis.
Wound healing is a dynamic process requiring a coordinated response. Cells respond to both biochemical and biophysical cues within their microenvironment, together modulating cellular responses.
Despite the remarkable ability of nanomedicines to diagnose and treat disease, activation of the immune system and the development of innate and adaptive immunity against specific subsets of nanomedicines is a significant unresolved challenge.